High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
Br J Clin Pharmacol
; 89(1): 232-241, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-35947524
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Helicobacter pylori
/
Helicobacter Infections
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido